In individuals with ICH, selective inhibitors of the NLRP3 inflammasome reduce the polarization of M1 microglia around the hematoma, increase the number of M2 cells, and reduce neuroinflammation after ICH (61, 115). Here, NLRP3 is linked to hematoma.